Call Anytime

+66 98-828-1773

At Dr. StemCellsThailand, we are dedicated to advancing the field of regenerative medicine through innovative cellular therapies and stem cell treatments. With over 20 years of experience, our expert team is committed to providing personalized care to patients from around the world, helping them achieve optimal health and vitality. We take pride in our ongoing research and development efforts, ensuring that our patients benefit from the latest advancements in stem cell technology. Our satisfied patients, who come from diverse backgrounds, testify to the transformative impact of our therapies on their lives, and we are here to support you on your journey to wellness.

Visiting Hours

Gallery Posts

Blog Details

Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD) is a systemic disorder of mineral and bone metabolism due to CKD, characterized by abnormalities in calcium, phosphorus, parathyroid hormone (PTH), vitamin D metabolism, bone turnover, mineralization, volume, linear growth, or strength, and vascular or other soft tissue calcification12368.

Mineral and Bone Disorder (MBD)

Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD) is a systemic disorder of mineral and bone metabolism due to CKD, characterized by abnormalities in calcium, phosphorus, parathyroid hormone (PTH), vitamin D metabolism, bone turnover, mineralization, volume, linear growth, or strength, and vascular or other soft tissue calcification12368.

Mineral and Bone Disorder (MBD) in Chronic Kidney Disease (CKD-MBD)

Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD) is a systemic disorder of mineral and bone metabolism due to CKD, characterized by abnormalities in calcium, phosphorus, parathyroid hormone (PTH), vitamin D metabolism, bone turnover, mineralization, volume, linear growth, or strength, and vascular or other soft tissue calcification12368.

Definition

CKD-MBD is defined as a systemic disorder of mineral and bone metabolism due to CKD manifested by one or a combination of:

  • Abnormalities of calcium, phosphorus, PTH, or vitamin D metabolism
  • Abnormalities in bone turnover, mineralization, volume, linear growth, or strength
  • Vascular or other soft tissue calcification

This broader term replaces the older concept of renal osteodystrophy, which referred mainly to bone pathology, by encompassing both skeletal and extraskeletal manifestations368.

Pathophysiology

  • As kidney function declines (starting around CKD stage 3), phosphate excretion decreases, leading to hyperphosphatemia.
  • Reduced renal synthesis of active vitamin D (calcitriol) causes hypocalcemia and decreased intestinal calcium absorption.
  • Hypocalcemia and hyperphosphatemia stimulate parathyroid hormone (PTH) secretion, leading to secondary hyperparathyroidism.
  • Elevated fibroblast growth factor 23 (FGF23) further suppresses calcitriol production and phosphate reabsorption.
  • These disturbances cause abnormal bone remodeling and promote vascular and soft tissue calcifications, contributing to cardiovascular disease, a leading cause of death in CKD patients1267.

Clinical Manifestations

  • Bone pain, fractures, skeletal deformities
  • Muscle weakness
  • Pruritus (itching)
  • Vascular calcification leading to cardiovascular morbidity and mortality
  • Growth retardation in children with CKD
  • Increased risk of cardiovascular events due to arterial calcification23567.

Diagnosis

  • Laboratory tests: Serum calcium, phosphorus, PTH, alkaline phosphatase, vitamin D levels
  • Imaging: Bone X-rays, bone mineral density studies, vascular imaging for calcifications
  • Bone biopsy: Gold standard for assessing bone turnover and mineralization abnormalities (renal osteodystrophy component)138.

Management

  • Control serum phosphate with dietary restriction and phosphate binders
  • Supplement vitamin D or use active vitamin D analogs to suppress PTH
  • Use calcimimetics to manage secondary hyperparathyroidism
  • Monitor and manage calcium levels carefully to avoid hypercalcemia
  • Address cardiovascular risk factors and monitor for vascular calcifications
  • Kidney transplantation is the definitive treatment to correct CKD-MBD abnormalities2358.

Summary Table

AspectDetails
DefinitionSystemic disorder of mineral and bone metabolism due to CKD
Key FeaturesAbnormal calcium, phosphorus, PTH, vitamin D metabolism; bone abnormalities; vascular calcification
PathophysiologyHyperphosphatemia, hypocalcemia, secondary hyperparathyroidism, elevated FGF23
Clinical SignsBone pain, fractures, pruritus, vascular calcifications, cardiovascular disease
DiagnosisLab tests, imaging, bone biopsy
TreatmentPhosphate control, vitamin D therapy, calcimimetics, dialysis, transplantation

Consult with Our Team of Experts Now!
At DrStemCellsThailand (DRSCT)‘s Anti-Aging and Regenerative Medicine Center of Thailand, we emphasize comprehensive evaluations and personalized treatment plans of Cellular Therapy and Stem Cells for managing various health conditions. If you have questions about Mineral and Bone Disorder (MBD) or would like more information on our services, consult with our experts today!

Consult with Our Team of Experts Now!

References

  1. Chronic Kidney Disease-Mineral Bone Disorder (CKD-MBD) – NCBI
    https://www.ncbi.nlm.nih.gov/books/NBK560742/
  2. Mineral & Bone Disorder in Chronic Kidney Disease – NIDDK
    https://www.niddk.nih.gov/health-information/kidney-disease/mineral-bone-disorder
  3. Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD) – Dove Press
    https://doi.org/10.2147/IJNRD.S203715
  4. Mineral and Bone Disorder – National Kidney Foundation
    https://www.kidney.org/kidney-topics/mineral-and-bone-disorder
  5. Chronic kidney disease mineral and bone disorder – RACGP
    https://www1.racgp.org.au/ajgp/2023/january-february/chronic-kidney-disease-mineral-and-bone-disorder
  6. Chronic kidney disease–mineral and bone disorder – Wikipedia
    https://en.wikipedia.org/wiki/Chronic_kidney_disease%E2%80%93mineral_and_bone_disorder
  7. Chronic kidney disease–mineral and bone disorder: conclusions – Kidney International
    https://doi.org/10.1016/j.kint.2024.02.025
  8. KDIGO Clinical Practice Guideline Update for CKD-MBD
    https://kdigo.org/guidelines/ckd-mbd/

CKD-MBD is a multifaceted disorder linking kidney dysfunction with bone abnormalities and vascular calcifications, requiring comprehensive management to reduce morbidity and mortality in CKD patients.

Leave A Comment

Your email address will not be published. Required fields are marked *